Latest Articles

Publication Date
All News Scientific
N-Acetylcysteine in Endometriosis: A Systematic Review of Biological Rationale and Clinical Evidence.

Endometriosis is a chronic inflammatory and estrogen-dependent disease in which oxidative stress, immune dysregulation, and lesion-supportive microenvironmental signaling contribute to lesion development. N-acetylcysteine (NAC), a glutathione-replenishing and redox-modulating agent, has …

Published: July 16, 2026, midnight
Read Full Article
N-acetyl-L-cysteine N-acetylcysteine antioxidants drug repurposing endometrioma endometriosis inflammation non-hormonal therapy oxidative stress
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype - londoninsider.co.uk

Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype londoninsider.co.uk

Published: July 15, 2026, 11:49 p.m.
Read Full Article
The many potential symptoms of endometriosis - Contemporary OB/GYN

The many potential symptoms of endometriosis Contemporary OB/GYN

Published: July 15, 2026, 8 p.m.
Read Full Article
Dual Chamber Prefilled Syringes Market Size, Industry Analysis, Demand & Forecast 2035 - Global Growth Insights

Dual Chamber Prefilled Syringes Market Size, Industry Analysis, Demand & Forecast 2035 Global Growth Insights

Published: July 15, 2026, 7:28 p.m.
Read Full Article
Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer - Benzinga

Merck Says Blockbuster Keytruda Outperforms Chemotherapy in Advanced Endometrial Cancer Benzinga

Published: July 15, 2026, 5:25 p.m.
Read Full Article
Clinical and surgical diagnosis of endometriosis, with Heather Appelbaum, MD - Contemporary OB/GYN

Clinical and surgical diagnosis of endometriosis, with Heather Appelbaum, MD Contemporary OB/GYN

Published: July 15, 2026, 5:16 p.m.
Read Full Article
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer - OncLive

Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer OncLive

Published: July 15, 2026, 3:58 p.m.
Read Full Article
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace

Published: July 15, 2026, 3:11 p.m.
Read Full Article
AI for employee burnout: How leaders can help, not harm - Caledonian Record

AI for employee burnout: How leaders can help, not harm Caledonian Record

Published: July 15, 2026, 3:01 p.m.
Read Full Article
Stem cell science unlocks more mysteries of the menstrual cycle - Medical Xpress

Stem cell science unlocks more mysteries of the menstrual cycle Medical Xpress

Published: July 15, 2026, 2 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!